CoronaVac’s first batch arrives in Brazil. Anvisa has not yet authorized the use of the Covid´s vaccine

CoronaVac’s first batch arrives in Brazil. Anvisa has not yet authorized the use of the Covid´s vaccine

By Agency Brazil 11/19/2020 11:20

 The material landed at Guarulhos International Airport

The first 120 thousand doses of CoronaVac, vaccine against Covid-19, developed by the Sinovac laboratory, in partnership with the Butantan Institute, arrived this Thursday morning, in Brazil, in São Paulo. The material was imported from China by the government of São Paulo and landed at Guarulhos International Airport. CoronaVac is one of four vaccines against the new coronavirus (Sars-CoV-2) that are being tested in Brazil.

This viagra uk sale type is also referred to as “non-insulin-dependent diabetes mellitus” (NIDDM) or “adult-onset diabetes”. Basically, it is not chemically addictive on cialis line but it will surely taper off the problem in minutes. The use of levitra prescription to effectively treat erection-related problems such as erectile dysfunction or also known as impotence and is different from other men’s sexual health is erectile dysfunction (ED). Your protection generic cialis australia and your quality of life must come first. The São Paulo government signed an agreement to purchase 46 million doses and to transfer technology to the Butantan Institute. However, the National Health Surveillance Agency (Anvisa) has not yet authorized the use of the vaccine, which is in the third phase of testing, when applied to humans. So far the vaccine has shown safety and efficacy, according to studies. The governor of São Paulo, João Doria, the director of the Butantan Institute, Dimas Covas, and the state secretary of health, Jean Gorinchtey, accompanied the arrival of the lot.

[huge_it_slider id=”15″]

Leave a Reply

Your email address will not be published. Required fields are marked *

− 5 = 1